Tag: aveo pharmaceuticals
Why do companies in the Midwest continue to invest in biotech?
This story has been updated to include the following statement from Purdue Pharma: We’re grateful for the support and encouragement of our customers, our stakeholders, our community, our shareholders and the broader community that has helped us realize our vision of bringing innovative new therapies to people with cancer.Purdue Pharma is committed to delivering the […]
Continue Reading...
How to make money in Indian pharmaceuticals: How to cash in on the booming Indian drug market
How to become an expert at a fast-growing market, but at a significant loss?This article will help you navigate the ever-changing landscape of Indian pharmaceutical companies, and you’ll find a wealth of information in the process.The basics: How much are the drug companies making per share?How do they make it?How much are you willing to […]
Continue Reading...
Aveo Pharmaceuticals, Tracon Pharmaceuticals trade in short-term gains
Avea Pharmaceuticals is trading in short term gains for its new drug, Tracons drug, which is a combination of aripiprazole and aripic acid.The drug, called Aptensio, has been approved for treating patients with multiple sclerosis and spinal muscular atrophy, and is being used in trials for people with type 1 diabetes.The stock gained 1.8 percent […]
Continue Reading...